ITGAM and neoplasm: Tumor cells of control (n=3) and treated (n=3) mice were investigated by flow cytometric analysis for expression levels of common myeloid differentiation markers and CD11b expression was significantly increased in the tumor cells from the BFA-treated mice (Figure 7d).